Cellular senescence is a state in which a cell stops dividing in a durable way while remaining metabolically active. It is not the same as cell death, and it is not simply another word for an old cell. Senescence can arise after stresses such as DNA damage, and it has both useful and potentially harmful roles.

Why a cell might stop dividing

A damaged cell that continues multiplying could pass problems to daughter cells. A stable growth arrest can therefore be protective in some settings. Senescent cells also participate in tissue responses. The consequences depend on the cell type, the trigger, the tissue and whether the cells are removed appropriately.

Some senescent cells release mixtures of signaling molecules that alter surrounding cells and immune activity. Persistent accumulation can contribute to an unfavorable tissue environment, but it is inaccurate to describe every senescent cell as useless or uniformly harmful. NIH’s SenNet program is developing ways to identify and catalogue these varied states rather than assuming one universal senescent-cell signature. NIH: A new framework for senescence research

How researchers identify senescence

No single marker establishes senescence in every tissue. Researchers combine evidence about growth arrest, molecular changes, secreted factors and cellular context. A marker that rises during senescence may also change for other reasons. This makes claims based on one blood measurement especially difficult to interpret.

Why removal is not a simple “reset”

A treatment intended to eliminate certain senescent cells must distinguish them from cells the body needs. It must also show that removal improves an important outcome without creating a new problem. A reduction in one laboratory marker does not establish rejuvenation.

The useful mental model is a state of altered cell behavior, not a single villain. Understanding where and when senescence helps or harms is a central part of the research.